# Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics

> **NCT02042664** · PHASE3 · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 44 (actual)

## Conditions studied

- Obesity
- Diabetes

## Interventions

- **DRUG:** BYETTA treatment
- **DRUG:** Metformine

## Key facts

- **NCT ID:** NCT02042664
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-06
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02042664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02042664, "Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02042664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*